p.11 抽出テキスト

CLINICAL STATEMENTS AND GUIDELINES

Circulation. 2023;148:e9–e119. DOI: 10.1161/CIR.0000000000001168 August 29, 2023

Virani et al 2023 AHA/ACC/ACCP/ASPC/NLA/PCNA Chronic Coronary Disease Guideline

this guideline will address established diagnostic, risk stratification, and treatment approaches in a contemporary context, new therapies, and the intersection between CCD and other comorbid diseases in a framework that recognizes the importance of shared decision-making, team-based care, and cost and value.

Figure 2. “Ever Told You Had Angina or CHD?” Age-Adjusted US Prevalence, by State (BRFSS Prevalence and Trends Data, 2019). BRFSS indicates Behavioral Risk Factor Surveillance System; and CHD, coronary heart disease. Source: BRFSS prevalence and trends data. Reprinted with permission from Tsao CW et al.1 Copyright 2022 American Heart Association, Inc. Original figure has been modified to remove white space between map and legend.

Figure 3. Global Age-Adjusted Prevalence of CCD per 100 000, by Sex, 2020. CCD indicates chronic coronary disease. Modified with permission from Tsao CW et al.1 Copyright 2022 American Heart Association, Inc. Source: Data courtesy of the Global Burden of Disease Study 2020, Institute for Health Metrics and Evaluation. Used with permission. All rights reserved. Copyright © 2021 University of Washington. More information is available on the Global Burden of Disease Study website.5

Downloaded from http://ahajournals.org by on October 7, 2026